Drugs
September 2007: Additions and Deletions to the Drug Product List
27th Edition: Cumulative Supplement Number 9
NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.6 Cumulative Supplement Legend.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE
TABLET; ORAL
>D> WYGESIC
>D> AA + LEITNER PHARMS 650MG;65MG N84999 001 Se DISC
>A> @ 650MG;65MG N84999 001 Se DISC
ALBUTEROL
AEROSOL, METERED; INHALATION
>D> PROVENTIL
>D> BN + SCHERING 0.09MG/INH N17559 001 Se DISC
>A> @ 0.09MG/INH N17559 001 Se DISC
ALBUTEROL SULFATE
SOLUTION; INHALATION
ACCUNEB
>D> + DEY EQ 0.021% BASE N20949 002 Apr 30, 2001 Se CFTG
>A> AN + EQ 0.021% BASE N20949 002 Apr 30, 2001 Se CFTG
>A> ALBUTEROL SULFATE
>A> AN WATSON LABS EQ 0.021% BASE N77772 001 Sep 25, 2007 Se NEWA
>A> AN EQ 0.042% BASE N77772 002 Sep 25, 2007 Se NEWA
AMLODIPINE BESYLATE
>A> TABLET, ORALLY DISINTEGRATING; ORAL
>A> AMLODIPINE BESYLATE
>A> SYNTHON PHARMS EQ 2.5MG BASE N22026 001 Sep 27, 2007 Se NEWA
>A> EQ 5MG BASE N22026 002 Sep 27, 2007 Se NEWA
>A> + EQ 10MG BASE N22026 003 Sep 27, 2007 Se NEWA
TABLET; ORAL
AMLODIPINE BESYLATE
>A> AB WATSON LABS EQ 2.5MG BASE N77073 001 Sep 26, 2007 Se NEWA
>A> AB EQ 5MG BASE N77073 002 Sep 26, 2007 Se NEWA
>A> AB EQ 10MG BASE N77073 003 Sep 26, 2007 Se NEWA
>A> AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL
>A> TABLET; ORAL
>A> AZOR
>A> DAIICHI SANKYO EQ 5MG BASE;20MG N22100 001 Sep 26, 2007 Se NEWA
>A> EQ 5MG BASE;40MG N22100 002 Sep 26, 2007 Se NEWA
>A> EQ 10MG BASE;20MG N22100 003 Sep 26, 2007 Se NEWA
>A> + EQ 10MG BASE;40MG N22100 004 Sep 26, 2007 Se NEWA
AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE;
TABLET; ORAL
ADDERALL 10
>A> AB DURAMED RES 2.5MG;2.5MG;2.5MG;2.5MG N11522 007 Feb 13, 1996 Se CAHN
>D> AB SHIRE 2.5MG;2.5MG;2.5MG;2.5MG N11522 007 Feb 13, 1996 Se CAHN
ADDERALL 12.5
>A> AB DURAMED RES 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 Aug 31, 2000 Se CAHN
>D> AB SHIRE 3.125MG;3.125MG;3.125MG;3.125MG N11522 012 Aug 31, 2000 Se CAHN
ADDERALL 15
>A> AB DURAMED RES 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 Aug 31, 2000 Se CAHN
>D> AB SHIRE 3.75MG;3.75MG;3.75MG;3.75MG N11522 013 Aug 31, 2000 Se CAHN
ADDERALL 20
>A> AB DURAMED RES 5MG;5MG;5MG;5MG N11522 008 Feb 13, 1996 Se CAHN
>D> AB SHIRE 5MG;5MG;5MG;5MG N11522 008 Feb 13, 1996 Se CAHN
ADDERALL 30
>A> AB + DURAMED RES 7.5MG;7.5MG;7.5MG;7.5MG N11522 010 May 12, 1997 Se CAHN
>D> AB + SHIRE 7.5MG;7.5MG;7.5MG;7.5MG N11522 010 May 12, 1997 Se CAHN
ADDERALL 5
>A> AB DURAMED RES 1.25MG;1.25MG;1.25MG;1.25MG N11522 009 May 12, 1997 Se CAHN
>D> AB SHIRE 1.25MG;1.25MG;1.25MG;1.25MG N11522 009 May 12, 1997 Se CAHN
ADDERALL 7.5
>A> AB DURAMED RES 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 Aug 31, 2000 Se CAHN
>D> AB SHIRE 1.875MG;1.875MG;1.875MG;1.875MG N11522 011 Aug 31, 2000 Se CAHN
ANAGRELIDE HYDROCHLORIDE
CAPSULE; ORAL
AGRYLIN
>D> AB + SHIRE EQ 1MG BASE N20333 002 Mar 14, 1997 Se DISC
>A> @ EQ 1MG BASE N20333 002 Mar 14, 1997 Se DISC
BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM
TABLET, DELAYED RELEASE, FOR SOLUTION; ORAL
HALFLYTELY
>A> + BRAINTREE 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2. N21551 002 Sep 24, 2007 Se NEWA
CALCIPOTRIENE
>D> OINTMENT; TOPICAL
>D> DOVONEX
>D> + LEO PHARM 0.005% N20273 001 Dec 29, 1993 Se DISC
>A> @ 0.005% N20273 001 Dec 29, 1993 Se DISC
CARBOPLATIN
INJECTABLE; INJECTION
CARBOPLATIN
>D> AP PHARMACHEMIE 50MG/VIAL N76162 001 Oct 14, 2004 Se CRLD
>A> AP + 50MG/VIAL N76162 001 Oct 14, 2004 Se CRLD
>D> AP 150MG/VIAL N76162 002 Oct 14, 2004 Se CRLD
>A> AP + 150MG/VIAL N76162 002 Oct 14, 2004 Se CRLD
>D> AP 450MG/VIAL N76162 003 Oct 14, 2004 Se CRLD
>A> AP + 450MG/VIAL N76162 003 Oct 14, 2004 Se CRLD
>D> PARAPLATIN
>D> AP + BRISTOL MYERS 50MG/VIAL N19880 001 Mar 03, 1989 Se DISC
>A> @ 50MG/VIAL N19880 001 Mar 03, 1989 Se DISC
>D> AP + 150MG/VIAL N19880 002 Mar 03, 1989 Se DISC
>A> @ 150MG/VIAL N19880 002 Mar 03, 1989 Se DISC
>D> AP + 450MG/VIAL N19880 003 Mar 03, 1989 Se DISC
>A> @ 450MG/VIAL N19880 003 Mar 03, 1989 Se DISC
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>D> AP PHARMACHEMIE EQ 50MG/5ML (10MG/ML) N77269 001 Oct 14, 2004 Se CRLD
>A> AP + EQ 50MG/5ML (10MG/ML) N77269 001 Oct 14, 2004 Se CRLD
>D> AP EQ 150MG/15ML (10MG/ML) N77269 002 Oct 14, 2004 Se CRLD
>A> AP + EQ 150MG/15ML (10MG/ML) N77269 002 Oct 14, 2004 Se CRLD
>D> AP EQ 450MG/45ML (10MG/ML) N77269 003 Oct 14, 2004 Se CRLD
>A> AP + EQ 450MG/45ML (10MG/ML) N77269 003 Oct 14, 2004 Se CRLD
>D> AP TEVA PARENTERAL EQ 50MG/5ML (10MG/ML) N77139 001 Sep 21, 2005 Se CRLD
>A> AP + EQ 50MG/5ML (10MG/ML) N77139 001 Sep 21, 2005 Se CRLD
>D> AP EQ 150MG/15ML (10MG/ML) N77139 002 Sep 21, 2005 Se CRLD
>A> AP + EQ 150MG/15ML (10MG/ML) N77139 002 Sep 21, 2005 Se CRLD
>D> AP EQ 450MG/45ML (10MG/ML) N77139 003 Sep 21, 2005 Se CRLD
>A> AP + EQ 450MG/45ML (10MG/ML) N77139 003 Sep 21, 2005 Se CRLD
>D> AP EQ 600MG/60ML (10MG/ML) N77139 004 Sep 21, 2005 Se CRLD
>A> AP + EQ 600MG/60ML (10MG/ML) N77139 004 Sep 21, 2005 Se CRLD
CARISOPRODOL
>A> TABLET; ORAL
>A> SOMA
>A> MEDPOINTE PHARM 250MG N11792 004 Sep 13, 2007 Se NEWA
CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX
CAPSULE, EXTENDED RELEASE; ORAL
>A> TUSSICAPS
>A> TYCO HLTHCARE EQ 4MG MALEATE;EQ 5MG N77273 002 Sep 24, 2007 Se NEWA
>A> + EQ 8MG MALEATE;EQ 10MG N77273 001 Sep 24, 2007 Se NEWA
CICLOPIROX
SOLUTION; TOPICAL
>A> CICLOPIROX
>A> AT ACTAVIS MID 8% N78046 001 Sep 18, 2007 Se NEWA
>A> AT APOTEX CORP 8% N78172 001 Sep 18, 2007 Se NEWA
>A> AT G AND W LABS 8% N78233 001 Sep 18, 2007 Se NEWA
>A> AT HI TECH PHARMA 8% N78270 001 Sep 18, 2007 Se NEWA
>A> AT PERRIGO NEW YORK 8% N77623 001 Sep 18, 2007 Se NEWA
>A> AT SYNERX PHARMA 8% N78567 001 Sep 18, 2007 Se NEWA
>A> AT TARO PHARM INDS 8% N78144 001 Sep 18, 2007 Se NEWA
>A> AT TEVA PHARMS 8% N78079 001 Sep 18, 2007 Se NEWA
>A> AT TOLMAR 8% N77687 001 Sep 18, 2007 Se NEWA
>A> AT WATSON LABS 8% N78124 001 Sep 18, 2007 Se NEWA
PENLAC
>D> + SANOFI AVENTIS US 8% N21022 001 Dec 17, 1999 Se CFTG
>A> AT + 8% N21022 001 Dec 17, 1999 Se CFTG
CLOPIDOGREL BISULFATE
TABLET; ORAL
PLAVIX
>A> SANOFI AVENTIS US EQ 300MG BASE N20839 002 Sep 20, 2007 Se NEWA
CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE
SYRUP; ORAL
PHENERGAN VC W/ CODEINE
>A> @ ANI PHARMS 10MG/5ML;5MG/5ML;6.25MG/5ML N08306 005 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 10MG/5ML;5MG/5ML;6.25MG/5ML N08306 005 Apr 02, 1984 Se CAHN
CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN W/ CODEINE
>A> @ ANI PHARMS 10MG/5ML;6.25MG/5ML N08306 004 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 10MG/5ML;6.25MG/5ML N08306 004 Apr 02, 1984 Se CAHN
CYANOCOBALAMIN
SPRAY, METERED; NASAL
CALOMIST
>D> @ FLEMING 25UGM/SPRAY N22102 001 Jul 27, 2007 Se CMFD
>A> + 25UGM/SPRAY N22102 001 Jul 27, 2007 Se CMFD
DEXRAZOXANE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> TOTECT
>A> @ TOPOTARGET EQ 500MG BASE/VIAL N22025 001 Sep 06, 2007 Se DISC
DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN W/ DEXTROMETHORPHAN
>A> @ ANI PHARMS 15MG/5ML;6.25MG/5ML N11265 002 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 15MG/5ML;6.25MG/5ML N11265 002 Apr 02, 1984 Se CAHN
ESTRADIOL VALERATE
INJECTABLE; INJECTION
DELESTROGEN
>D> + KING PHARMS 10MG/ML N09402 002 Se CTEC
>A> AO + 10MG/ML N09402 002 Se CTEC
ESTRADIOL VALERATE
>A> AO SANDOZ 10MG/ML N40628 001 Oct 04, 2007 Se NEWA
>A> AO 20MG/ML N40628 002 Oct 04, 2007 Se NEWA
>A> AO 40MG/ML N40628 003 Oct 04, 2007 Se NEWA
FERUMOXIDES
INJECTABLE; INJECTION
FERIDEX I.V.
>D> + ADV MAGNETICS EQ 11.2MG IRON/ML N20416 001 Aug 30, 1996 Se CAHN
>A> + AMAG PHARMS INC EQ 11.2MG IRON/ML N20416 001 Aug 30, 1996 Se CAHN
FERUMOXSIL
SUSPENSION; ORAL
GASTROMARK
>D> + ADV MAGNETICS EQ 0.175MG IRON/ML N20410 001 Dec 06, 1996 Se CAHN
>A> + AMAG PHARMS INC EQ 0.175MG IRON/ML N20410 001 Dec 06, 1996 Se CAHN
FLOXURIDINE
INJECTABLE; INJECTION
FLOXURIDINE
>D> AP BEDFORD 500MG/VIAL N75387 001 Apr 16, 2000 Se CRLD
>A> AP + 500MG/VIAL N75387 001 Apr 16, 2000 Se CRLD
>D> FUDR
>D> AP + HOSPIRA 500MG/VIAL N16929 001 Se DISC
>A> @ 500MG/VIAL N16929 001 Se DISC
FLUDARABINE PHOSPHATE
INJECTABLE; INJECTION
FLUDARABINE PHOSPHATE
>A> AP + EBEWE PHARMA 50MG/2ML(25MG/ML) N22137 001 Sep 21, 2007 Se NEWA
>D> + TEVA PARENTERAL 50MG/2ML (25MG/ML) N76661 001 Apr 28, 2004 Se CTEC
>A> AP + 50MG/2ML (25MG/ML) N76661 001 Apr 28, 2004 Se CTEC
FLUDEOXYGLUCOSE F-18
INJECTABLE; INTRAVENOUS
FLUDEOXYGLUCOSE F18
>A> + FEINSTEIN 20-200mCi/ML N21870 001 Aug 19, 2005 Se CAHN
>D> + NORTH SHORE LIJ 20-200mCi/ML N21870 001 Aug 19, 2005 Se CAHN
GABAPENTIN
CAPSULE; ORAL
GABAPENTIN
>A> AB HIKMA 100MG N78150 001 Sep 25, 2007 Se NEWA
>A> AB 300MG N78150 002 Sep 25, 2007 Se NEWA
>A> AB 400MG N78150 003 Sep 25, 2007 Se NEWA
GADODIAMIDE
INJECTABLE; INJECTION
ONMISCAN
>A> + GE HEALTHCARE 14.35GM/50ML(287MG/ML) N22066 001 Sep 05, 2007 Se NEWA
>A> + 28.7GM/100ML(287MG/ML) N22066 002 Sep 05, 2007 Se NEWA
HYDROCHLOROTHIAZIDE
CAPSULE; ORAL
HYDROCHLOROTHIAZIDE
>A> AB AUROBINDO 12.5MG N78164 001 Sep 18, 2007 Se NEWA
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>A> AB APOTEX 25MG N40774 001 Oct 03, 2007 Se NEWA
>A> AB 50MG N40774 002 Oct 03, 2007 Se NEWA
>A> AB LANNETT 25MG N84325 001 Se CMFD
>A> AB 50MG N84324 001 Se CMFD
>D> @ PHARMERAL 25MG N84325 001 Se CMFD
>D> @ 50MG N84324 001 Se CMFD
HYDROCORTISONE BUTYRATE
CREAM; TOPICAL
LOCOID
>D> AB + FERNDALE LABS 0.1% N18514 001 Mar 31, 1982 Se CAHN
>A> AB + TRIAX PHARMS 0.1% N18514 001 Mar 31, 1982 Se CAHN
LOCOID LIPOCREAM
>D> + FERNDALE LABS 0.1% N20769 001 Sep 08, 1997 Se CAHN
>A> + TRIAX PHARMS 0.1% N20769 001 Sep 08, 1997 Se CAHN
LOTION; TOPICAL
LOCOID
>D> + FERNDALE LABS 0.1% N22076 001 May 18, 2007 Se CAHN
>A> + TRIAX PHARMS 0.1% N22076 001 May 18, 2007 Se CAHN
OINTMENT; TOPICAL
LOCOID
>D> AB + FERNDALE LABS 0.1% N18652 001 Oct 29, 1982 Se CAHN
>A> AB + TRIAX PHARMS 0.1% N18652 001 Oct 29, 1982 Se CAHN
SOLUTION; TOPICAL
LOCOID
>D> AT + FERNDALE LABS 0.1% N19116 001 Feb 25, 1987 Se CAHN
>A> AT + TRIAX PHARMS 0.1% N19116 001 Feb 25, 1987 Se CAHN
HYDROMORPHONE HYDROCHLORIDE
TABLET; ORAL
HYDROMORPHONE HYDROCHLORIDE
>D> KV PHARM 2MG N77311 001 Nov 09, 2005 Se CTEC
>A> AB 2MG N77311 001 Nov 09, 2005 Se CTEC
>D> 4MG N77311 002 Nov 09, 2005 Se CTEC
>A> AB 4MG N77311 002 Nov 09, 2005 Se CTEC
>A> AB TYCO HLTHCARE 2MG N78273 001 Sep 19, 2007 Se NEWA
>A> AB 4MG N78273 002 Sep 19, 2007 Se NEWA
HYDROXYCHLOROQUINE SULFATE
TABLET; ORAL
HYDROXYCHLOROQUINE SULFATE
>A> AB ZYDUS PHARMS 200MG N40657 001 Sep 21, 2007 Se NEWA
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
INJECTABLE; INJECTION
>A> HUMALOG MIX 50/50 KWIKPEN
>A> + LILLY 50 UNITS/ML;50 UNITS/ML N21018 002 Sep 06, 2007 Se NEWA
>A> HUMALOG MIX 75/25 KWIKPEN
>A> + LILLY 75 UNITS/ML;25 UNITS/ML N21017 002 Sep 06, 2007 Se NEWA
INSULIN LISPRO RECOMBINANT
INJECTABLE; INJECTION
>A> HUMALOG KWIKPEN
>A> + LILLY 100 UNITS/ML N20563 003 Sep 06, 2007 Se NEWA
LANTHANUM CARBONATE
TABLET, CHEWABLE; ORAL
FOSRENOL
>D> SHIRE EQ 250MG BASE N21468 001 Oct 26, 2004 Se DISC
>A> @ EQ 250MG BASE N21468 001 Oct 26, 2004 Se DISC
LEUCOVORIN CALCIUM
INJECTABLE; INJECTION
LEUCOVORIN CALCIUM
>D> AP BEDFORD EQ 50MG BASE/VIAL N89384 001 Sep 14, 1987 Se CRLD
>A> AP + EQ 50MG BASE/VIAL N89384 001 Sep 14, 1987 Se CRLD
>D> AP EQ 100MG BASE/VIAL N89717 001 Mar 28, 1988 Se CRLD
>A> AP + EQ 100MG BASE/VIAL N89717 001 Mar 28, 1988 Se CRLD
LEVOTHYROXINE SODIUM
>D> CAPSULE; ORAL
>D> TIROSINT
>D> INST BIOCHIMIQUE 0.013MG N22121 001 Aug 01, 2007 Se DISC
>A> @ 0.013MG N22121 001 Aug 01, 2007 Se DISC
>D> 0.025MG N21924 002 Oct 13, 2006 Se DISC
>A> @ 0.025MG N21924 002 Oct 13, 2006 Se DISC
>D> 0.05MG N21924 003 Oct 13, 2006 Se DISC
>A> @ 0.05MG N21924 003 Oct 13, 2006 Se DISC
>D> 0.075MG N21924 004 Oct 13, 2006 Se DISC
>A> @ 0.075MG N21924 004 Oct 13, 2006 Se DISC
>D> 0.1MG N21924 005 Oct 13, 2006 Se DISC
>A> @ 0.1MG N21924 005 Oct 13, 2006 Se DISC
>D> 0.125MG N21924 006 Oct 13, 2006 Se DISC
>A> @ 0.125MG N21924 006 Oct 13, 2006 Se DISC
>D> + 0.15MG N21924 007 Oct 13, 2006 Se DISC
>A> @ 0.15MG N21924 007 Oct 13, 2006 Se DISC
TABLET; ORAL
>D> LEVOLET
>D> BX VINTAGE 0.025MG N21137 001 Jun 06, 2003 Se DISC
>A> @ 0.025MG N21137 001 Jun 06, 2003 Se DISC
>D> BX 0.05MG N21137 002 Jun 06, 2003 Se DISC
>A> @ 0.05MG N21137 002 Jun 06, 2003 Se DISC
>D> BX 0.075MG N21137 003 Jun 06, 2003 Se DISC
>A> @ 0.075MG N21137 003 Jun 06, 2003 Se DISC
>D> BX 0.088MG N21137 004 Jun 06, 2003 Se DISC
>A> @ 0.088MG N21137 004 Jun 06, 2003 Se DISC
>D> BX 0.1MG N21137 005 Jun 06, 2003 Se DISC
>A> @ 0.1MG N21137 005 Jun 06, 2003 Se DISC
>D> BX 0.112MG N21137 006 Jun 06, 2003 Se DISC
>A> @ 0.112MG N21137 006 Jun 06, 2003 Se DISC
>D> BX 0.125MG N21137 007 Jun 06, 2003 Se DISC
>A> @ 0.125MG N21137 007 Jun 06, 2003 Se DISC
>D> BX 0.137MG N21137 008 Jun 06, 2003 Se DISC
>A> @ 0.137MG N21137 008 Jun 06, 2003 Se DISC
>D> BX 0.15MG N21137 009 Jun 06, 2003 Se DISC
>A> @ 0.15MG N21137 009 Jun 06, 2003 Se DISC
>D> BX 0.175MG N21137 010 Jun 06, 2003 Se DISC
>A> @ 0.175MG N21137 010 Jun 06, 2003 Se DISC
>D> BX 0.2MG N21137 011 Jun 06, 2003 Se DISC
>A> @ 0.2MG N21137 011 Jun 06, 2003 Se DISC
>D> BX 0.3MG N21137 012 Jun 06, 2003 Se DISC
>A> @ 0.3MG N21137 012 Jun 06, 2003 Se DISC
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC;
INJECTABLE; INJECTION
ISOLYTE S PH 7.4 IN PLASTIC CONTAINER
>D> B BRAUN 30MG/100ML;37MG/100ML;0.82MG/10 N19696 001 Sep 29, 1989 Se CRLD
>A> + 30MG/100ML;37MG/100ML;0.82MG/10 N19696 001 Sep 29, 1989 Se CRLD
METHIMAZOLE
TABLET; ORAL
METHIMAZOLE
>A> AB CARACO 5MG N40870 001 Sep 25, 2007 Se NEWA
>A> AB 10MG N40870 002 Sep 25, 2007 Se NEWA
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP SANDOZ 1MG/ML N77360 001 Oct 02, 2007 Se NEWA
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
MINOCIN
>D> AB + TRIAX PHARMS EQ 100MG BASE N50649 002 May 31, 1990 Se CRLD
>A> AB EQ 100MG BASE N50649 002 May 31, 1990 Se CRLD
MINOCYCLINE HYDROCHLORIDE
>D> AB TEVA EQ 100MG BASE N63009 001 Mar 02, 1992 Se CRLD
>A> AB + EQ 100MG BASE N63009 001 Mar 02, 1992 Se CRLD
>D> MORICIZINE HYDROCHLORIDE
>D> TABLET; ORAL
>D> ETHMOZINE
>D> SHIRE 200MG N19753 001 Jun 19, 1990 Se DISC
>A> @ 200MG N19753 001 Jun 19, 1990 Se DISC
>D> 250MG N19753 002 Jun 19, 1990 Se DISC
>A> @ 250MG N19753 002 Jun 19, 1990 Se DISC
>D> + 300MG N19753 003 Jun 19, 1990 Se DISC
>A> @ 300MG N19753 003 Jun 19, 1990 Se DISC
MORPHINE SULFATE
INJECTABLE; INJECTION
MORPHINE SULFATE
>D> AP MALLINCKRODT 1MG/ML N20631 001 Jul 03, 1996 Se DISC
>A> @ 1MG/ML N20631 001 Jul 03, 1996 Se DISC
>D> + 2MG/ML N20631 002 Jul 03, 1996 Se DISC
>A> @ 2MG/ML N20631 002 Jul 03, 1996 Se DISC
TABLET, EXTENDED RELEASE; ORAL
MORPHINE SULFATE
>A> AB KV PHARM 100MG N77855 001 Sep 27, 2007 Se NEWA
>A> AB 200MG N77855 002 Sep 27, 2007 Se NEWA
NIFEDIPINE
TABLET, EXTENDED RELEASE; ORAL
NIFEDIPINE
>A> AB2 OSMOTICA PHARM 90MG N77410 001 Oct 03, 2007 Se NEWA
OFLOXACIN
SOLUTION/DROPS; OTIC
FLOXIN OTIC
>D> + DAIICHI 0.3% N20799 001 Dec 16, 1997 Se CFTG
>A> AT + 0.3% N20799 001 Dec 16, 1997 Se CFTG
>A> OFLOXACIN
>A> AT APOTEX INC 0.3% N76527 001 Sep 28, 2007 Se NEWA
OXCARBAZEPINE
TABLET; ORAL
>A> OXCARBAZEPINE
>A> AB GLENMARK 150MG N77802 001 Oct 09, 2007 Se NEWA
>A> AB 300MG N77802 002 Oct 09, 2007 Se NEWA
>A> AB 600MG N77802 003 Oct 09, 2007 Se NEWA
>A> AB ROXANE 150MG N77795 001 Oct 09, 2007 Se NEWA
>A> AB 300MG N77795 002 Oct 09, 2007 Se NEWA
>A> AB 600MG N77795 003 Oct 09, 2007 Se NEWA
TRILEPTAL
>D> NOVARTIS 150MG N21014 001 Jan 14, 2000 Se CFTG
>A> AB 150MG N21014 001 Jan 14, 2000 Se CFTG
>D> 300MG N21014 002 Jan 14, 2000 Se CFTG
>A> AB 300MG N21014 002 Jan 14, 2000 Se CFTG
>D> + 600MG N21014 003 Jan 14, 2000 Se CFTG
>A> AB + 600MG N21014 003 Jan 14, 2000 Se CFTG
PEMETREXED DISODIUM
INJECTABLE; IV (INFUSION)
ALIMTA
>A> + LILLY EQ 100MG BASE/VIAL N21462 002 Sep 07, 2007 Se NEWA
PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN VC
>A> @ ANI PHARMS 5MG/5ML;6.25MG/5ML N08604 003 Apr 02, 1984 Se CAHN
>D> @ WYETH AYERST 5MG/5ML;6.25MG/5ML N08604 003 Apr 02, 1984 Se CAHN
PRAMLINTIDE ACETATE
INJECTABLE; SUBCUTANEOUS
SYMLIN
>A> AMYLIN EQ 1.5MG BASE/1.5ML (EQ 1MG N21332 002 Sep 25, 2007 Se NEWA
>A> EQ 2.7MG BASE/2.7ML (EQ 1MG N21332 003 Sep 25, 2007 Se NEWA
>D> + EQ 3MG BASE/5ML (EQ 0.6MG N21332 001 Mar 16, 2005 Se CPOT
>A> + EQ 3MG BASE/5ML (EQ 600UGM N21332 001 Mar 16, 2005 Se CPOT
PREDNISOLONE
SYRUP; ORAL
PREDNISOLONE
>A> AA VINTAGE 15MG/5ML N40775 001 Sep 21, 2007 Se NEWA
PROMETHAZINE HYDROCHLORIDE
SYRUP; ORAL
PHENERGAN FORTIS
>A> @ ANI PHARMS 25MG/5ML N08381 003 Se CAHN
>D> @ WYETH AYERST 25MG/5ML N08381 003 Se CAHN
PHENERGAN PLAIN
>A> @ ANI PHARMS 6.25MG/5ML N08381 004 Apr 18, 1984 Se CAHN
>D> @ WYETH AYERST 6.25MG/5ML N08381 004 Apr 18, 1984 Se CAHN
QUININE SULFATE
CAPSULE; ORAL
>A> QUALAQUIN
>A> + AR HOLDING CO 324MG N21799 001 Aug 12, 2005 Se CTNA
>D> QUININE SULFATE
>D> + AR HOLDING CO 324MG N21799 001 Aug 12, 2005 Se CTNA
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
RANITIDINE HYDROCHLORIDE
>A> AA APOTEX EQ 15MG BASE/ML N77602 001 Sep 17, 2007 Se NEWA
>A> AA PHARM ASSOC EQ 15MG BASE/ML N77405 001 Sep 21, 2007 Se NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>D> PROCTER AND 5MG N20835 002 Apr 14, 2000 Se CFTG
>A> AB 5MG N20835 002 Apr 14, 2000 Se CFTG
>D> 30MG N20835 001 Mar 27, 1998 Se CFTG
>A> AB 30MG N20835 001 Mar 27, 1998 Se CFTG
>D> + 35MG N20835 003 May 25, 2002 Se CFTG
>A> AB + 35MG N20835 003 May 25, 2002 Se CFTG
>A> RISEDRONATE SODIUM
>A> AB TEVA PHARMS 5MG N77132 001 Oct 05, 2007 Se NEWA
>A> AB 30MG N77132 002 Oct 05, 2007 Se NEWA
>A> AB 35MG N77132 003 Oct 05, 2007 Se NEWA
SELEGILINE
FILM, EXTENDED RELEASE; TRANSDERMAL
EMSAM
>D> SOMERSET 6MG/24HR N21336 001 Feb 27, 2006 Se CRLD
>A> + 6MG/24HR N21336 001 Feb 27, 2006 Se CRLD
>D> + 12MG/24HR N21336 003 Feb 27, 2006 Se CRLD
>A> 12MG/24HR N21336 003 Feb 27, 2006 Se CRLD
SODIUM POLYSTYRENE SULFONATE
SUSPENSION; ORAL, RECTAL
>A> KIONEX
>A> AA PADDOCK 15GM/60ML N40028 001 Sep 17, 2007 Se NEWA
TERBINAFINE HYDROCHLORIDE
>A> GRANULE; ORAL
>A> LAMISIL
>A> NOVARTIS EQ 125MG BASE/PACKET N22071 001 Sep 28, 2007 Se NEWA
>A> + EQ 187.5MG BASE/PACKET N22071 002 Sep 28, 2007 Se NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
None for this month.
